sanguinarine has been researched along with bq 123 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apers, S; Caballero-George, C; Claeys, M; Gupta, MP; Pieters, L; Solis, PN; Van den Heuvel, H; Vanderheyden, PM; Vauquelin, G; Vlietinck, AJ | 1 |
1 other study(ies) available for sanguinarine and bq 123
| Article | Year |
|---|---|
Inhibitory activity on binding of specific ligands to the human angiotensin II AT(1) and endothelin 1 ET(A) receptors: bioactive benzo[c]phenanthridine alkaloids from the root of Bocconia frutescens.
Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Isoquinolines; Ligands; Molecular Structure; Papaveraceae; Peptides, Cyclic; Phenanthridines; Plant Extracts; Plant Roots; Quantitative Structure-Activity Relationship; Receptor, Angiotensin, Type 1; Receptor, Endothelin A; Receptors, Angiotensin; Receptors, Endothelin; Tritium; Tumor Cells, Cultured | 2002 |